A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years
PHASE3
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Adolesc...
Status
Completed
Location
Huaiyin District Center for Disease Control and prevention
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
PHASE3
The purpose of this study is to evaluate the immunogenicity and safety of G...
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age
PHASE3
The purpose of this study is to evaluate consistency in terms of the immune...